![Judge's Order Likely to Derail Federal Rule Clarifying 340B Drug Discount Program](https://cdn.cancerletter.com/media/2015/10/22222118/41-38-340B.jpg)
![Judge's Order Likely to Derail Federal Rule Clarifying 340B Drug Discount Program](https://cdn.cancerletter.com/media/2015/10/22222118/41-38-340B.jpg)
Cover Story
Many people love the 340B Drug Pricing Program.
By Tessa Vellek
By Tessa Vellek
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Trending Stories
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Supreme Court removes “Chevron deference,” threatening drug regulation, health coverage, delivery of cancer care
- Elizabeth Comen joins NYU Langone Health’s Perlmutter Cancer Center
- Trump et al. are wrong: Biden Cancer Initiative is not to be confused with the Beau Biden Cancer Moonshot
- Edward Sondik, electrical engineer turned public health expert and one-time interim NCI director, dies at 82
- A modest proposal from a former FDA commissioner: Add antidepressants to the nation’s water supply
Warning: This is not a public health recommendation. Do not implement.